Globe Newswire » Trang Công Nghệ | Trangcongnghe.vn

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease

Globenewswire -

ThreatLocker® launches new solutions, further advances Zero Trust security resilience and adoption

ThreatLocker® launches new solutions, further advances Zero Trust security resilience and adoption

Globenewswire -

Philips publishes its Annual Report 2024

Philips publishes its Annual Report 2024

Globenewswire -

Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.

Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.

Globenewswire -

Sport Business Global Golf Report: PGA Tour adapts to new challenges as women’s game grows

Sport Business Global Golf Report: PGA Tour adapts to new challenges as women’s game grows

Globenewswire -

Philips and Mass General Brigham announce collaboration to improve patient care with live AI-powered insights

Philips and Mass General Brigham announce collaboration to improve patient care with live AI-powered insights

Globenewswire -

Pacific Green Signs Agreement to Sell Its 250MW / 500MWh Limestone Coast North Battery Energy Park Development

Pacific Green Signs Agreement to Sell Its 250MW / 500MWh Limestone Coast North Battery Energy Park Development

Globenewswire -

XEM THÊM TIN MỚI